Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
RASAGILINE FORMULATIONS OF IMPROVED CONTENT UNIFORMITY
No-Receipt date
2019-00762 - 21/02/2019
No-Filing date
20190400583 - 21/02/2019
No-Granting date
3089724.B2 - 13/03/2019
No-EPO application date
06720975.9 - 22/02/2006
No-EPO granting date
1848402 - 20/02/2019
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
3/2019 - 09/05/2019
Expiration date
23/02/2026
Kind of title
Amended European Patent Validation
Legal status
NOT VALID
Priorities
US655622 P23/02/2005/US
US720908 P27/09/2005/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/205
A61K 9/00
A61K 9/14
A61K 9/20
Related Documents
Related Titles
Type
Master title
Related title
[ADD]
20160401910
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1007601
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
5 BASEL STREET, P.O. BOX 3190
49131 PETACH-TIKVA
ISRAEL
Inventors
Code
Firstname
Surname
2529985
PESKIN, TIRTZA, BERGER
Representatives
Code
Firstname
Surname
Address
Town
Zip
3098
ANNA
GIAKOUMI
ALKAMENOUS 12-14
ATHINA (ATTIKIS)
10439
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8397
ANDRONIKI
MISIOU
ANALIPSEOS 23 KAI MARATHONOS 27
VRILISSIA (ATTIKIS)
15235
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
9/9/2020 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 08/2020_ Αρ. Πρωτ. ΓΔ 1413_ 09/09/2020
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).